Clinical Trial: A Comparative Bioavailability Study of Two Torasemide 10 mg Tablets Formulations in Healthy Adult Participants Under Fasting Conditions:

U.S., Oct. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07201584) titled 'A Comparative Bioavailability Study of Two Torasemide 10 mg Tablets Formulations in Healthy Adult Participants Under Fasting Conditions:' on Sept. 10.

Brief Summary: The purpose of this study is to evaluate the bioavailability, safety and tolerability of Torasemide 10 mg tablets (Berlin-Chemie AG), compared to Unat(R) 10 tablets (Viatris Healthcare GmbH) in healthy adult participants under fasting conditions.

Study Start Date: Sept. 05

Study Type: INTERVENTIONAL

Condition: Healthy Adult Male and Female Volunteers

Intervention: DRUG: Torasemide tablet 10 mg

Tablets by Berlin-Chemie AG (Germany)

DRUG: Unat(R) 10 tablets (Torase...